OpenAI cuts funding target by $10bn, seeks about $20bn at $1.25tn valuation
Financial Times reporting indicates OpenAI has cut its fundraising target by ten billion dollars and is now pursuing roughly twenty billion at a valuation of one point two five trillion dollars, framing the move as a tempering of ambitions amid broader tech-sector anxieties. Separate feed excerpts from The Decoder and The Information describe Chinese AI labs shifting attention toward OpenAI's GPT-6 Astra model as a primary target after Anthropic tightened defenses, with one headline characterizing Astra as a top distillation target. Together these items portray OpenAI under simultaneous pressure on capital markets and frontier-model security, though the available excerpts do not specify round timing, investor demand, or verified scale of external probing. Operators should treat funding figures as reported targets rather than closed deals.
OpenAI cuts funding target by $10bn, seeks about $20bn at $1.25tn valuation
Financial Times reporting says OpenAI slashed its funding target by $10bn amid mounting tech anxieties. The ChatGPT maker is now seeking about $20bn at a $1.25tn valuation as it tempers its ambitions.
Key takeaway
Even OpenAI is reportedly scaling back how much capital it seeks, which may reflect tighter scrutiny of AI valuations at the frontier.
What happened
Financial Times reporting says OpenAI slashed its funding target by $10bn amid mounting tech anxieties, and the ChatGPT maker is now seeking about $20bn at a $1.25tn valuation as it tempers its ambitions.
The Decoder reports that Chinese AI labs are now mainly tapping OpenAI's most powerful model, GPT-6 Astra, instead of Anthropic's Claude after Anthropic tightened its defenses; a related Information headline describes OpenAI's Astra as a top distillation target for China's AI labs.
Evidence
OpenAI cut its funding target by $10bn and seeks about $20bn at a $1.25tn valuation
Financial Times Technology · attributed
ChatGPT maker is now seeking about $20bn at a $1.25tn valuation as it tempers its ambitions
Chinese AI labs are mainly targeting GPT-6 Astra instead of Claude after Anthropic tightened defenses
The Decoder · attributed
Chinese AI labs are now mainly tapping OpenAI's most powerful model, GPT-6 Astra, instead of Anthropic's Claude.
OpenAI's Astra is described as a top distillation target for Chinese AI labs
The Information AI · attributed
OpenAI's Astra Model Becomes Top Distillation Target for China's AI Labs The Information
Why it matters
Builders and operators may face stricter capital expectations alongside heightened need to harden access around the most capable models if adversarial attention shifts toward Astra.
Limits and uncertainties
The excerpt on funding does not establish the reasons for the cut, the timeline, or whether the round has closed, and it does not specify what tech anxieties refers to.
The Decoder excerpt does not establish what tapping entails, how defenses were tightened, or any verified outcomes; The Information item in the packet is headline-level only.
Practical implications
Do not read the shorter funding item as proof of a broader AI funding downturn without investor demand, terms, or closure details.
Treat reports of shifted adversarial focus as a signal to review model access controls rather than as confirmation of scale or method.
What to watch
Whether OpenAI confirms or closes a round near the reported $20bn target at the cited $1.25tn valuation
Further reporting with specifics on distillation or probing activity against GPT-6 Astra and Anthropic defense changes
